數據港(603881.SH):上海旭灃完成減持計劃 累計減持87.8萬股
格隆匯1月2日丨數據港(603881.SH)公佈,本次減持前,上海旭灃商務信息諮詢合夥企業(普通合夥)(以下簡稱“上海旭灃”)持有公司股份總數為351.2萬股;佔公司總股本的1.67%;其中公司副總裁徐軍持有上海旭灃33.33%股份,構成間接持股關係。
公司於1月2日收到上海旭灃的《關於減持上海數據港股份有限公司股份結果的告知函》。截至2019年12月31日,上海旭灃通過集中競價交易方式,減持公司股份87.8萬股,減持計劃實施完畢;減持後,上海旭灃持有公司股份總數263.4萬股,佔公司股本總數的1.25%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.